← MyLongPath

PPI / reflux management

MedicationClinical1 review
+3
Average score out of 5
Based on 1 experience(s)

Class of medications that reduce gastric acid production. Used to treat gastroesophageal reflux disease (GERD) symptoms and other digestive issues sometimes reported in Long COVID.

Information
Subcategory
Gastric acid secretion inhibitor
Evidence level
3/5
Evidence type
Symptomatic use
Score distribution
+5
0 (0%)
+3
1 (100%)
+1
0 (0%)
0
0 (0%)
Negative
0 (0%)
Latest reviews
F
Anonymous review+3
26-35 y.o. · 4/22/2026
Share your experience

Your feedback helps thousands of people find what really works.

Join the community